THE MD-224 DIARIES

AT 56Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely made TPD methods. With this critique, we target both preclinical experiments and clinical trials to supply a comprehensive summary of the security and scientific success of PROTACs and MGDs in hematologic malignancies in the last 20 years.